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Background/Aims: Recent data from Western populations 
have suggested that patients with sporadic duodenal adeno-
mas are at a higher risk for the development of colorectal 
neoplasia. In this study, we compared the frequency of 
colorectal neoplasia in patients with sporadic duodenal ad-
enomas to healthy control subjects. Methods: This retrospec-
tive case-control study used the databases of 3 teaching hos-
pitals in Gyeonggi-do Province, South Korea. The colonoscopy 
ﬁ  ndings of patients with sporadic duodenal adenomas were 
compared with those of age- and gender-matched healthy 
individuals who had undergone gastroduodenoscopies and 
colonoscopies during general screening examinations. Re-
sults: Between 2001 and 2008, 45 patients were diagnosed 
endoscopically with sporadic duodenal adenomas; 26 (58%) 
of these patients received colonoscopies. Colorectal neopla-
sia (42% vs 21%; odds ratio [OR], 2.8; 95% conﬁ  dence inter-
val [CI], 1.1 to 7.4) and advanced colorectal adenoma (19% 
vs 3%; OR, 9.0; 95% CI, 1.6 to 50.0) were signiﬁ  cantly more 
common in patients with sporadic duodenal adenomas than 
in healthy control subjects. Conclusions: Compared with 
healthy individuals, patients with sporadic duodenal adeno-
mas were at a signiﬁ  cantly higher risk for developing colorec-
tal neoplasia. Such at-risk patients should undergo routine 
screening colonoscopies. (Gut Liver 2011;5:432-436)
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INTRODUCTION
Duodenal adenomas are common in patients with genetic 
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syndromes, such as familial adenomatous polyposis (FAP).
1 Spo-
radic duodenal adenomas are rare. Few endoscopic series have 
been published to date; these have reported a 0.1% to 0.3% in-
cidence of duodenal adenomas.
2-5 Because duodenal adenomas 
have a high rate (35% to 85%) of malignant transformation, 
endoscopic or surgical removal is typically recommended.
6-8 
Recent studies of Western populations
4,5,9-13 have suggested that 
patients with sporadic duodenal adenomas are at higher risk for 
the development of colorectal neoplasia.
The diagnosis and management of duodenal adenomas in 
Asia have been based solely on a few small case series.
14-17 
Although colorectal neoplasia are thought to be less common 
among Asians than in Western populations,
18 recent stud-
ies
19,20 have shown an increasing trend for the development of 
this condition in Asian populations. However, the association 
between sporadic duodenal adenomas and the development of 
colorectal neoplasia in Asian populations has not been fully 
examined. The purpose of this study was to compare the fre-
quencies of colorectal neoplasia in patients with sporadic duo-
denal adenomas to in age- and gender-matched healthy control 
subjects who had undergone routine gastroduodenoscopies and 
colonoscopies.
MATERIALS AND METHODS
1. Patients and study design
In this retrospective case-control study, we collected data 
from the endoscopy and pathology databases of 3 teaching hos-
pitals (Uijeongbu and Incheon St. Mary’s Hospitals, St. Vincent’s 
Hospital) in Gyeonggi-do Province, South Korea. The Catholic 
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for this study. Cases treated at these hospitals from 2001 to 
2008 were considered for inclusion. Patients whose duodenal 
adenoma diagnosis had been confirmed by upper gastrointes-
tinal (GI) endoscopy and histology, and who had undergone 
colonoscopy, were included in the study sample. Patients with 
ampullary tumors or personal and/or family histories of FAP, 
hereditary nonpolyposis colorectal cancer (HNPCC), or familial 
colorectal cancer were excluded.
The endoscopic and clinical data of patients in the study sam-
ple were examined to identify diagnoses of colorectal neoplasia. 
The location, number, size, and histological characteristics of 
duodenal and colorectal neoplasias were recorded, as were the 
indications for and interval of time between endoscopy and 
colonoscopy. Duodenal and colorectal adenomas were classi-
fied as low- or high-grade, according to the Vienna classifica-
tion.
21 Patients with multiple lesions were classified according to 
the most advanced lesion. Advanced adenomas (duodenal and 
colorectal) were defined by size (≥10 mm), tubulovillous (villous 
component >20%) or villous histology, and/or high-grade dys-
plasia. Advanced colorectal neoplasm was defined as colorectal 
cancer or advanced adenoma. The findings in each patient with 
a duodenal adenoma were compared with those of 3 randomly 
selected age- and gender-matched asymptomatic subjects who 
had undergone upper GI endoscopies and colonoscopies during 
routine screening between January 2001 and December 2008. 
Control subjects with histories of colon-cancer surgery or pol-
ypectomy, or personal or family histories of FAP, HNPCC, or 
familial colorectal cancer were excluded.
2. Statistical analyses
Statistical analyses were performed using the SPSS software 
version 12.0 (SPSS Inc., Chicago, IL, USA). Data are expressed 
as proportions or medians/means and ranges, as appropriate. 
Predictors of colorectal neoplasia were tested using conditional 
logistic regression. Odds ratios (ORs) and 95% confidence inter-
vals (CIs) were used to compare the rates of colorectal neoplasia 
in patients with and without duodenal adenomas. p-values of 
less than 0.05 were considered to indicate statistical signifi-
cance.
RESULTS
1. Sporadic duodenal adenomas
From January 2001 to December 2008, 45 patients (22 males, 
23 females; mean age, 59.6 years; range, 33 to 86 years) were 
diagnosed with sporadic duodenal adenomas. Abdominal pain 
was the indication for upper GI endoscopy in more than half 
(51%) of these cases. Other indications were anemia (11%), 
melena (4%), nausea and vomiting (11%), diarrhea (4%), indica-
tions requiring endoscopic retrograde cholangiopancreatogra-
phy (2%), and screening for gastric cancer (16%). A single duo-
denal adenoma was identified in each of the 45 patients; these 
lesions were located in the duodenal bulb (n=20, 44%), descend-
ing duodenum (n=16, 36%) (Fig. 1), and ampullary region (n=9; 
20%). Adenoma size was reported for 38 patients (84%); mean 
size was 17.6 mm (median, 14.5 mm; range, 5 to 50 mm). Large 
(≥10 mm) duodenal adenomas were found in 33 patients (73%) 
and were classified as advanced, based on size (n=33), villous 
histology (n=3), and/or presence of high-grade dysplasia (n=11). 
There was no significant correlation among adenoma location, 
size, and histological stage.
2. Colorectal neoplasias associated with duodenal adeno-
mas
Colonoscopies were performed in 26 (58%; 12 males, 14 fe-
males) patients with sporadic duodenal adenomas; colorectal 
neoplasia were diagnosed in 11 (42%) of these patients. The 
mean age of these patients was 58.4 (range, 37 to 76) years and 
none had a family history of colorectal cancer. Four patients 
with colorectal neoplasia had synchronous multiple lesions and 
7 patients had a single neoplasm. Four colorectal neoplasia were 
located in the rectum or sigmoid colon, 2 were in the descend-
ing colon, and 5 were above the splenic flexure; proximal neo-
plasia occurred in 45% of cases. The mean size of the colorectal 
neoplasia was 11 mm (median, 8 mm; range, 5 to 23 mm). Ten 
patients (39%) had at least one adenoma; 8 of these showed 
low-grade dysplasia and 2 showed high-grade dysplasia. Of 
the 8 adenomas exhibiting low-grade dysplasia, three were ad-
vanced (size ≥10 mm, n=3; villous component, n=2). In total, 5 
patients (19%) had advanced adenomas. One patient (4%) had 
a colorectal adenocarcinoma located in the cecum, which was 
diagnosed concurrently with duodenal adenoma. Advanced 
colorectal neoplasia (advanced adenoma+adenocarcinoma) 
was found in 6 of 26 patients (23%) with duodenal adenomas 
who had undergone colonoscopies. We found no significant 
Fig. 1. Endoscopic view of a sporadic duodenal adenoma. A pedun-
culated tumor is located in the descending portion of the duodenum.434  Gut and Liver, Vol. 5, No. 4, December 2011
relationship between duodenal adenoma location and the pres-
ence or nature of colorectal neoplasia. Colonoscopies had been 
performed before the diagnosis of duodenal adenoma in 7 (27%) 
of 26 patients. In this group, the mean interval between colo-
noscopy and endoscopy was 11.6 (range, 3 to 22) months. The 
most common indication for colonoscopy was the occurrence of 
a duodenal adenoma (39%). Other indications were abdominal 
pain (19%), anemia (11%), altered bowel habits (8%), constipa-
tion (11%), and diarrhea (11%). We found no significant rela-
tionship between indications for colonoscopy and the presence 
or nature of colorectal neoplasia.
3. Control subjects
The control sample included 78 subjects (36 males, 42 fe-
males) who were matched by age and gender with the study 
sample (3 control subjects per case). Their mean age was 58.4 
(range, 41 to 76) years. The control subjects were asymptomatic 
Korean adults who had undergone colonoscopies and upper GI 
endoscopies during routine screening at one of the participat-
ing hospitals during the study period. No control subject had 
a family history of colorectal cancer and none had previously 
undergone a colonoscopy. In the control group, 16 subjects 
(21%) presented with colorectal neoplasias (Table 1). Two (3%) 
adenomas were advanced (25 mm, low-grade dysplasia; 10 mm, 
high-grade dysplasia) and 14 (18%) were not. The mean size of 
the colorectal adenomas was 7.3 mm (median, 5 mm; range, 
3 to 25 mm). No control subject had a colorectal adenocarci-
noma. Comparison of the colonoscopy findings of patients with 
sporadic duodenal adenomas (n=26) with those of the control 
group (n=78) revealed that colorectal neoplasias (42% vs 21%; 
OR, 2.8; 95% CI, 1.1 to 7.4; p=0.032) and advanced colorectal 
adenomas (19% vs 3%; OR, 9.0; 95% CI, 1.6 to 50.0; p=0.012) 
were significantly more common in patients with duodenal 
adenomas (Table 2). We found no significant difference in the 
frequency of colorectal cancer diagnoses (4% vs 0%) between 
patients with duodenal adenomas and the control group.
DISCUSSION
This study was performed to determine whether the risk of 
colorectal neoplasia was higher in Korean patients diagnosed 
with sporadic duodenal adenomas. We identified 45 sporadic 
duodenal adenomas among the patients of 3 hospitals during 
an 8-year study period. Most (73%) of these adenomas were ad-
vanced at the time of diagnosis. Few studies
14-17 have examined 
duodenal adenomas and adenocarcinomas in Asian countries, 
and reported sample sizes have been small. Duodenal adenomas 
without FAP have not been previously reported in this region. 
Among the 45 patients identified in this study, 26 underwent 
colonoscopies and 11 (42%) had colorectal neoplasias. This inci-
dence is consistent with that reported (31% to 56%) for Western 
populations.
4,5,9,10
In this study, the randomly selected control group was age- 
and gender-matched to the study sample. The frequencies of 
colorectal and advanced neoplasias in healthy control subjects 
were 21% and 3%, respectively. These results are consistent 
with those of a previous Korean colonoscopy screening study,
22 
which found colorectal neoplasia in 21.9% and advanced 
colorectal neoplasia in 2.4% of asymptomatic adults with no 
risk factor for colorectal cancer. In Western populations, the 
overall frequency of colorectal neoplasia has ranged from 20.4% 
to 37.5%, and that of advanced neoplasia has ranged from 4.9% 
to 10.5%.
23-25 The frequency of advanced neoplasia in average-
risk Koreans may thus be slightly lower than in Western popu-
lations. Geographical differences may play an important role 
in the development of advanced colorectal neoplasia. However, 
the frequency of colorectal cancer is increasing in Korea; the 
incidence of this disease rose from 20.4/100,000 individuals in 
1999 to 29.8/100,000 in 2005,
26 suggesting a transition from a 
low to a higher prevalence of advanced neoplasia in the Korean 
population.
The results of this study show that the risks for colorectal 
neoplasia (relative risk, 2.8; 95% CI, 1.1 to 7.4) and advanced 
colorectal adenoma (relative risk, 9.0; 95% CI, 1.6 to 50.0) in-
creased significantly (vs control group) in patients with sporadic 
duodenal adenomas. The wide confidence intervals suggest that 
this series lacked the statistical power necessary to establish firm 
outcome findings. Nevertheless, our results are consistent with 
data from Netherlands,
5 where colorectal neoplasia were found 
in 21 of 49 (43%) patients who had undergone colonoscopies; 
Table 1. Incidence of Colorectal Neoplasia among Patients with Spo-








All colorectal neoplasia 11 (42) 16 (21) 0.032
Nonadvanced adenoma 5 (19) 14 (18) 1.000
Advanced adenoma 5 (19) 2 (3) 0.012
Adenocarcinoma 1 (4) 0 (0) 1.000
Advanced neoplasia 6 (23) 2 (3) 0.004
Patients were classified according to the most advanced lesion identi-
fied at colonoscopy.
Data are presented as number (%).
Table 2. Odds Ratios for Significant Differences between Patients 
with Sporadic Duodenal Adenomas and Healthy Individuals
Case vs Control OR 95% CI p-value
All colorectal neoplasia   2.8 1.1-7.4 0.032
Advanced adenoma   9.0 1.6-50.0 0.012
Advanced neoplasia 11.4 2.1-60.8 0.004
OR, odds ratio; CI, confidence interval.Chung WC, et al: Colorectal Neoplasia in Korean Patients with Sporadic Duodenal Adenomas  435
13 (27%) of these cases were advanced neoplasias. In that popu-
lation, patients with sporadic duodenal adenomas had signifi-
cantly higher frequencies of colorectal neoplasias (OR, 3.6; 95% 
CI, 1.7 to 7.4) and advanced colorectal adenomas (OR, 7.8; 95% 
CI, 2.1 to 29.4) than observed in the symptomatic control group. 
An Australian study
4 showed a significant correlation between 
sporadic duodenal adenomas and colorectal neoplasia (OR, 2.4; 
95% CI, 1.1 to 5.4), and reported a greater frequency of colorec-
tal cancer in patients with sporadic duodenal adenomas than in 
the general population. In the present study, the absence of a 
significant difference in colorectal adenocarcinoma frequency 
between patients with duodenal adenomas (4%) and healthy 
control subjects (0%) may be due to the small number of cases 
or to ethnic differences.
The biological behavior of duodenal adenomas appears to be 
similar to that of colorectal adenomas; both show high rates of 
malignant transformation and recurrence after local excision.
7 
Duodenal adenomas and colorectal neoplasias may thus share 
common pathophysiological mechanisms, including genetic 
and/or environmental factors. However, the mechanism under-
lying the association between sporadic duodenal adenomas and 
colorectal neoplasias has not been described to date. Although 
patients with diagnosed FAP were excluded from this study, 
some patients in the study sample may have had undiagnosed 
or attenuated FAP. However, this possibility seems unlikely to 
be a major factor affecting our results, because no patient in 
this study had 10 or more colorectal adenomas, characteristic 
of patients with FAP.
27,28 Patients with known HNPCC were also 
excluded from this study because HNPCC is associated with a 
higher risk of small bowel cancer.
29
This study has some limitations. There were long intervals of 
time between upper GI endoscopies and colonoscopies in the 
study sample. Seven patients (27%) had undergone colonosco-
pies before the diagnosis of a duodenal adenoma, which should 
result in a lower apparent frequency of colorectal neoplasia with 
respect to age-matched control subjects. In the present study, we 
minimized the potential for selection bias by randomly selecting 
asymptomatic, average-risk, age- and gender-matched control 
subjects who had undergone routine colonoscopy screen-
ing. However, this control group was not representative of the 
general population because it consisted of self-referred asymp-
tomatic subjects who were likely to be more health-conscious 
and from a higher socio-economic group. Furthermore, we did 
not assess other known risk factors for colorectal cancer, such 
as cigarette smoking, alcohol consumption, and dietary habits. 
Colonoscopies were performed in only 26 of 45 patients in the 
study sample; this limitation may be attributed to the rarity of 
duodenal adenoma diagnosis in clinical practice and the retro-
spective study design. A larger prospective study that provides 
colonoscopies to all patients with sporadic duodenal adenomas 
is needed.
In conclusion, patients with sporadic duodenal adenomas 
had significantly higher frequencies of colorectal neoplasia and 
advanced colorectal adenoma than the control group. Patients 
with sporadic duodenal adenomas should thus receive routine 
colonoscopy screening to increase the detection rate of colorec-
tal neoplasias.
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